Cohen & Steers CEO acquires 1,401 CNS shares via dividend units
Cohen & Steers, Inc. (CNS) reported an insider equity transaction by its Chief Executive Officer and director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cohen & Steers, Inc. (CNS) reported an insider equity transaction by its Chief Executive Officer and director. On 11/20/2025, the reporting person acquired 1,401 shares of common stock at a price of $0, reported as an acquisition of dividend equivalent restricted stock units tied to the company’s fourth quarter 2025 dividend and accruing on previously granted unvested restricted stock units from January 2022, 2023, 2024 and 2025.
Following this transaction, the reporting person directly beneficially owns 1,288,432 shares of common stock. In addition, 305,000 shares are held indirectly through a limited liability company owned by a family trust, for which the reporting person disclaims beneficial ownership except to the extent of any pecuniary interest.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,401 | $0.00 | $0.00 |
| Holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Shares held in a limited liability company owned by a family trust. Mr. Harvey disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.
- F2. Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's fourth quarter 2025 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2022, January 2023, January 2024 and January 2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.